OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer
Lei Wang, Weihua Guo, Guo Zhikun, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101420-101420
Open Access | Times Cited: 25

Showing 25 citing articles:

Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1

Tumor associated macrophages in breast cancer progression: implications and clinical relevance
Maria Stavrou, Anastasia Constantinidou
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7

Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma
Jian Zou, Wei Han, Yan Hu, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access

CDKN2ALowcancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistance
Raquel Buj, Aidan R. Cole, John R. Danielson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Nanobody-based drug delivery systems for cancer therapy
Lin Liu, Bin Tu, Yao Sun, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113562-113562
Closed Access

Analysis of single-cell and spatial transcriptomics in TNBC cell-cell interactions
Yan Xin, Qiji Ma, Qiang Deng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Myeloid cells: key players in tumor microenvironments
Qiaomin Hua, Zhixiong Li, Yulan Weng, et al.
Frontiers of Medicine (2025)
Closed Access

New insights into cancer immune checkpoints landscape from single-cell RNA sequencing
Qian Wang, Jiahui He, Tianyu Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189298-189298
Closed Access

A highly resolved integrated transcriptomic atlas of human breast cancers
Andrew Chen, Lina Kroehling, Christina S. Ennis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma
Adam P. Jones, Michael Haley, Miriam Hernandez-Meadows, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

PD-L1 importance in malignancies comprehensive insights into the role of PD-L1 in malignancies: from molecular mechanisms to therapeutic opportunities
Mojdeh Soltani, Mohammad Abbaszadeh, Hamed Fouladseresht, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma
Xinyu Su, Donglin Kang, Jiayu Wang, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access

Cytoplasmic and nuclear programmed death ligand 1 expression in peritumoral stromal cells in breast cancer: Prognostic and predictive value
E. Yu. Zubareva, M. A. Senchukova, Natalia V Saidler
World Journal of Experimental Medicine (2025) Vol. 15, Iss. 2
Closed Access

Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
Inga-Maria Launonen, Iga Niemiec, María Mercedes Hincapié-Otero, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2045-2063.e10
Closed Access | Times Cited: 4

Pan-Cancer Analysis of KANK2: Clinical and Molecular Insights into Tumor Progression and Therapeutic Implications
Kai Zhao, Jie Lin, Yongzhi Li, et al.
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1149-1166
Open Access

Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment
Lingrong Hu, Chengliang Sun, Kai Yuan, et al.
Drug Discovery Today (2024), pp. 104181-104181
Closed Access | Times Cited: 2

Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era
Xin Xiong, Xin Wang, Cuicui Liu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1

Impact of senescence cell signature in patients with non-small cell carcinoma and melanoma receiving PD-L1/PD-1 inhibitors
Young Wha Koh, Jae-Ho Han, Seokjin Haam, et al.
Mechanisms of Ageing and Development (2024) Vol. 222, pp. 111999-111999
Closed Access | Times Cited: 1

CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers
Prahlad V. Raninga, Bijun Zeng, Davide Moi, et al.
Oncogene (2024)
Closed Access | Times Cited: 1

Single CAR-Dual target: Intracranial Delivery of Anti-PD-L1 CAR T Cells Effectively Eradicates Glioma and Immunosuppressive Cells in the Tumor Microenvironment.
María José Ulloa-Navas, Yan Luo, Jesus Emiliano Sanchez-Garavito, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Immunomodulatory Effects of Bioactive Polysaccharides from Pleurotus pulmonarius on LPS-stimulated THP-1 Human Macrophages
Munirah Mokhtar, Chiuan Herng Leow, Noor Fatmawati Mokhtar, et al.
Food Bioscience (2024), pp. 105729-105729
Closed Access

The Role of Innate Priming in Modifying Tumor-associated Macrophage Phenotype
Ben Topham, Barry D. Hock, Elisabeth Phillips, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 12
Open Access

Page 1

Scroll to top